A Study of MK0359 in Patients With Chronic Asthma (0359-013)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)

NCT01624974 ·Status: COMPLETED ·Phase: PHASE2

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)

NCT01656395 ·Status: TERMINATED ·Phase: PHASE2

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

NCT00092144 ·Status: COMPLETED ·Phase: PHASE3

Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )

NCT00968201 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)

NCT00739297 ·Status: COMPLETED ·Phase: PHASE1

Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)

NCT02720081 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

NCT01448954 ·Status: COMPLETED ·Phase: PHASE2

Study in Mild Asthmatic Patients

NCT00748306 ·Status: COMPLETED ·Phase: PHASE2

Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma

NCT00986037 ·Status: COMPLETED ·Phase: PHASE1

A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma

NCT01823016 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

NCT01629849 ·Status: COMPLETED ·Phase: PHASE1

A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)

NCT00535028 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00652392 ·Status: COMPLETED ·Phase: PHASE3

Single Dose Study of GSK1440115 in Patients With Asthma

NCT01424280 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller

NCT04092582 ·Status: COMPLETED ·Phase: PHASE2

OC000459 Bronchial Allergen Challenge

NCT01056692 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise

NCT00812929 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

NCT00870584 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate GSK2190915 in Subjects With Mild Asthma

NCT00812773 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

NCT00603278 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

NCT00603746 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

NCT06637371 ·Status: RECRUITING ·Phase: PHASE1

The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma

NCT00133042 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma

NCT00659659 ·Status: COMPLETED ·Phase: PHASE1

Study in Patients With Asthma

NCT00215358 ·Status: COMPLETED ·Phase: PHASE2